This trial looks at how well telehealth works in improving adherence to endocrine therapy for participants with hormone receptor positive breast cancer who have undergone surgery.
- Stage III Breast Cancer
- Stage IIA Breast Cancer
- Stage IIB Breast Cancer
- Stage IIIA Breast Cancer
- Stage I Breast Cancer
- Stage 0 Breast Cancer
- Stage IIIB Breast Cancer
- Stage II Breast Cancer
- Stage IB Breast Cancer
- Stage IA Breast Cancer
1 Primary · 3 Secondary · Reporting Duration: Up to one year
Side Effects for
3 Treatment Groups
Arm I (Standard of Care office Visits)
1 of 3
Arm III (Smart Pill Bottle, messaging)
1 of 3
Arm II (Standard of Care Office Visits, survey, telehealth)
1 of 3
285 Total Participants · 3 Treatment Groups
Primary Treatment: Quality-of-Life Assessment · No Placebo Group · Phase 2
Who is running the clinical trial?
Age 18+ · All Participants · 11 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
How many venues are implementing this scientific investigation?
"Five distinct healthcare centres are currently enrolling patients in this clinical trial. These include Jefferson Health - South Jersey, Jefferson Health - Northeast, and Thomas Jefefrson University situated within Washington Township, Torresdale and Willow Grove respectively; plus two additional sites." - Anonymous Online Contributor
Is enrollment available to individuals interested in participating in this trial?
"According to the information presented on clinicaltrials.gov, this medical trial is presently searching for participants. The study was initially published on July 31st 2019 and its details were last revised Oct 18th 2022." - Anonymous Online Contributor
Has the Quality-of-Life Assessment earned FDA authorization?
"Our team at Power assigned Quality-of-Life Assessment a score of 2 due to the lack of efficacy data in Phase 2 clinical trials, although there is evidence that suggests it is safe." - Anonymous Online Contributor
How many people have enrolled in this trial thus far?
"Affirmative. According to clinicaltrials.gov, the trial is open for enrolment and was initially posted on July 31st 2019 with a recent update on October 18th 2022. A total of 285 patients will be accepted across 5 different healthcare settings." - Anonymous Online Contributor